Utilities and disutilities for attributes of injectable treatments for type 2 diabetes

Autor:	Boye, Kristina S., Matza, Louis S., Walter, Kimberly N., Van Brunt, Kate, Palsgrove, Andrew C., Tynan, Aodan
Zdroj:	The European Journal of Health Economics, 2011 Jun 01. 12(3), 219-230.
Databáze:	JSTOR Journals
Externí odkaz:	https://www.jstor.org/stable/41474355 Zobrazit plný text záznamu Full text from SpringerLink